91 related articles for article (PubMed ID: 9788618)
1. Angiostatin suppresses malignant glioma growth in vivo.
Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
[TBL] [Abstract][Full Text] [Related]
2. A new approach to fighting cancer?
Sato TN
Proc Natl Acad Sci U S A; 1998 May; 95(11):5843-4. PubMed ID: 9600880
[No Abstract] [Full Text] [Related]
3. Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.
Di K; Lloyd GK; Abraham V; MacLaren A; Burrows FJ; Desjardins A; Trikha M; Bota DA
Neuro Oncol; 2016 Jun; 18(6):840-8. PubMed ID: 26681765
[TBL] [Abstract][Full Text] [Related]
4. New functional aspects of cathepsin D and cathepsin E.
Tsukuba T; Okamoto K; Yasuda Y; Morikawa W; Nakanishi H; Yamamoto K
Mol Cells; 2000 Dec; 10(6):601-11. PubMed ID: 11211863
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma.
Zhang AB; Mozaffari K; Aguirre B; Li V; Kubba R; Desai NC; Wei D; Yang I; Wadehra M
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765787
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model.
Tran TA; Kim YH; Duong TH; Thangaraj J; Chu TH; Jung S; Kim IY; Moon KS; Kim YJ; Lee TK; Lee CW; Yun H; Lee JJ; Lee HJ; Lee KH; Jung TY
Front Immunol; 2022; 13():1009484. PubMed ID: 36703992
[TBL] [Abstract][Full Text] [Related]
7. Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.
Hasbum A; Quintanilla J; Jr JAA; Ding MH; Levy A; Chew SA
Future Med Chem; 2021 Feb; 13(4):393-418. PubMed ID: 33399488
[TBL] [Abstract][Full Text] [Related]
8. C6 cell line: the gold standard in glioma research.
Giakoumettis D; Kritis A; Foroglou N
Hippokratia; 2018; 22(3):105-112. PubMed ID: 31641331
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of 7-O-succinyl macrolactin A tromethamine salt in the mouse glioma model.
Jin J; Choi SH; Lee JE; Joo JD; Han JH; Park SY; Kim CY
Oncol Lett; 2017 May; 13(5):3767-3773. PubMed ID: 28529591
[TBL] [Abstract][Full Text] [Related]
10. Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.
Kasala D; Yoon AR; Hong J; Kim SW; Yun CO
Nanomedicine (Lond); 2016 Jul; 11(13):1689-713. PubMed ID: 27348247
[TBL] [Abstract][Full Text] [Related]
11. Label-free delineation of brain tumors by coherent anti-Stokes Raman scattering microscopy in an orthotopic mouse model and human glioblastoma.
Uckermann O; Galli R; Tamosaityte S; Leipnitz E; Geiger KD; Schackert G; Koch E; Steiner G; Kirsch M
PLoS One; 2014; 9(9):e107115. PubMed ID: 25198698
[TBL] [Abstract][Full Text] [Related]
12. Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.
Liu J; Wang Y; Akamatsu Y; Lee CC; Stetler RA; Lawton MT; Yang GY
Prog Neurobiol; 2014 Apr; 115():138-56. PubMed ID: 24291532
[TBL] [Abstract][Full Text] [Related]
13. Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.
Zhang W; Fulci G; Wakimoto H; Cheema TA; Buhrman JS; Jeyaretna DS; Stemmer Rachamimov AO; Rabkin SD; Martuza RL
Neoplasia; 2013 Jun; 15(6):591-9. PubMed ID: 23730207
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic gene therapy in the treatment of malignant gliomas.
Gatson NN; Chiocca EA; Kaur B
Neurosci Lett; 2012 Oct; 527(2):62-70. PubMed ID: 22906922
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.
Zhang W; Fulci G; Buhrman JS; Stemmer-Rachamimov AO; Chen JW; Wojtkiewicz GR; Weissleder R; Rabkin SD; Martuza RL
Mol Ther; 2012 Jan; 20(1):37-45. PubMed ID: 21915104
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy and targeted toxins for glioma.
Castro MG; Candolfi M; Kroeger K; King GD; Curtin JF; Yagiz K; Mineharu Y; Assi H; Wibowo M; Ghulam Muhammad AK; Foulad D; Puntel M; Lowenstein PR
Curr Gene Ther; 2011 Jun; 11(3):155-80. PubMed ID: 21453286
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.
Shiau AL; Teo ML; Chen SY; Wang CR; Hsieh JL; Chang MY; Chang CJ; Chao J; Chao L; Wu CL; Lee CH
BMC Cancer; 2010 May; 10():245. PubMed ID: 20509975
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.
Rahman R; Smith S; Rahman C; Grundy R
J Oncol; 2010; 2010():251231. PubMed ID: 20414333
[TBL] [Abstract][Full Text] [Related]
19. An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.
Zhao Y; Xiao A; diPierro CG; Carpenter JE; Abdel-Fattah R; Redpath GT; Lopes MB; Hussaini IM
Am J Pathol; 2010 Jun; 176(6):3032-49. PubMed ID: 20413683
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.
Candolfi M; Kroeger KM; Muhammad AK; Yagiz K; Farrokhi C; Pechnick RN; Lowenstein PR; Castro MG
Curr Gene Ther; 2009 Oct; 9(5):409-21. PubMed ID: 19860655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
